</ref>
 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
 | |
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 2015 |
| Founder | Spyro Mousses |
| Headquarters | Scottsdale, Arizona, United States |
| Website | http://www.systemsoncology.com/ |
Systems Oncology
editSystems Oncology LLC is an Arizona-based biotechnology company that discoveries and develops cancer therapeutics. The company applies cognitive computing and multi-scalar systems modeling to mine massive data sets and uncover hidden therapeutic insights for cancer, and partners with academic institutes and pharmaceutical companies to accelerate development of cancer treatments [1].
In February 2017, Systems Oncology licensed in a patented drug compound from the University of Wisconsin-Milwaukee Research Foundation [2,3]. The compound alters the VDR’s action selectively, and block the local inactivation of vitamin D around the tumor micro-environment, without interfering with the systemic calcium regulation needed for normal health. Current evidence shows the compound has safely and effectively suppressed tumors in animal models [4]. Systems Oncology plans to work with pharmaceutical partners to co-develop this new agent into a cancer therapy [5].
References
edit2. http://uwm.edu/news/uwm-research-foundation-licenses-novel-cancer-drug/
4. https://www.sciencedaily.com/releases/2017/02/170208151438.htm
5. http://collegenewsupdates.com/uwm-research-foundation-licenses-novel-cancer-drug/
External links
edit